Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8772331

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8771648

    (Trimethoxyphenylamino) pyrimidinyl formulations

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8772306

    Method of administration of gamma hydroxybutyrate with monocarboxylate transporters

    Jazz Pharmaceuticals, Inc. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8771965

    Methods and compositions involving nucleotide repeat disorders

    The Board of Regents of the University of Texas System · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8771662

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8772483

    Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8772495

    5-lipoxygenase-activating protein inhibitor

    Panmira Pharmaceuticals, LLC · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8772482

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8772453

    Compositions for linking zinc finger modules

    Sangamo Biosciences, Inc. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8779001

    Stat3 inhibitors

    The United States of America Dept. of Health and Human Services (DHHS) · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8779128

    Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

    Sarepta Therapeutics, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8778997

    Antiviral treatments

    BioCryst Pharmaceuticals, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8778983

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8778938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8778876

    Small-molecule inhibitors of Dengue and West Nile virus proteases

    The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8778871

    Metastin derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8778671

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8778398

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Jazz Pharmaceuticals, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8778343

    Antibodies that bind tau oligomers

    The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8778391

    Flurbiprofen and muscle relaxant combinations

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8778608

    CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma

    The Regents of the University of California · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8778347

    Fluorescent neutralization and adherence inhibition assays

    SANOFI PASTEUR VAXDESIGN CORPORATION · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8778354

    Compositions and methods for modulating RSV infection and immunity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8778633

    Transcription factor modulator

    Molecular Discover Systems · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8778847

    Immunogenic peptides of influenza virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8778844

    Structured peptide processing

    BICYCLE THERAPEUTICS LIMITED · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8778870

    Modified factor IX polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8778934

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8778907

    Lactulose for bowel evacuation

    Cumberland Pharmaceuticals Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8778889

    Antimicrobial decapeptide oral hygiene treatment

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8778897

    Method of treatment using α-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8778898

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8778913

    Antimicrobial compositions for treating microbial infections

    The Regents of the University of California · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8778944

    Pyridazinone compounds

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8778940

    Chemical inducers of neurogenesis

    The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8778949

    1-(2-phenoxymethylphenyl)piperazine compounds

    Theravance Biopharma R&D IP, LLC · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8778980

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8779127

    Processes for preparing substituted pyrimidines

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8779090

    Methods and compositions for the treatment of heart failure and other disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8779094

    Low viscosity highly concentrated suspensions

    The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8779095

    LAT adapter molecule for enhanced T-cell signaling and method of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8781559

    Method of evaluating metabolism of the eye

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8779151

    Orally bioavailable caffeic acid related anticancer drugs

    The Board of Regents of the University of Texas System · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8779129

    Triazinedione derivatives as GABAB receptor modulators

    Addex Pharma, S.A. · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8779156

    Analogues for the treatment or prevention of flavivirus infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8779197

    Aryl amides useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8781750

    Cell-type-specific patterns of gene expression

    The Regents of the University of California · Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. AU 2012362562

    Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione

    CELGENE CORP [CH] · Granted Thu Jul 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.